Archives for October 2, 2026

NutraCast: Beyond the COA – Testing blind spots put brands at risk

As retailers and regulators demand greater confidence in product quality, brands are taking a closer look at what their testing actually proves.

NI+Market Moves: Supplement industry deals of Q3 2026

Deal activity across the supplement and wider wellness sector remained brisk in the third quarter of 2026, with strategic buyers and private equity firms placing big bets on premium brands, science-led portfolios and scalable manufacturing platforms.

Opinion piece

Drug preclusion: Consider the source

CRN, CHPA and AHPA are celebrating H.R. 10336 as a balanced compromise. But in the pursuit of regulatory certainty, has part of the supplement industry agreed to permanently enshrine the very pharmaceutical gatekeeping mechanism it has spent years fighting?

NI+Botanical safety: Is Article 8 fit for purpose?

In the European Union, Article 8 procedures are used to evaluate, restrict and remove potentially unsafe ingredients from the supplement market, but its use in recent years has been the subject of controversy.

Study: App-based personalized dietary coaching effective for weight loss

A study comparing app-based, personalized, and general dietary coaching for weight reduction found that all interventions achieved clinically meaningful weight loss of at least 5% and improvements in blood lipid levels.

Nova Mentis launches precision fermentation Hydroxytyrosol for next-gen longevity formulations

Biotech innovator Nova Mentis has launched Polyphenol-HT1, a hydroxytyrosol ingredient produced through precision fermentation, for longevity-focused formulations.

Science shorts: Biotics, ginger and protein in the spotlight

This round-up highlights the latest health and nutrition research findings, including new findings on probiotics, postbiotics and ginger supplementation and how consuming different proteins could affect plasma levels of advanced glycation end products.